Adrenas Therapeutics Inc clinical trials
A subsidiary of BridgeBio
The registry lists 2 studies whose lead sponsor is Adrenas Therapeutics Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 23, 2025.
Registry sponsor names on this page
- Adrenas Therapeutics Inc2 studies
Something wrong with this grouping? Tell us on the BridgeBio page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All BridgeBio studies →
- A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)Active, not recruitingNCT04783181Phase 1/2
Sponsor listed in the registry: Adrenas Therapeutics Inc
- A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])CompletedNCT05101902
Sponsor listed in the registry: Adrenas Therapeutics Inc